Skip to main content
IMDX logo
IMDX
(NASDAQ)
Insight Molecular Diagnostics Inc.
$6.19-- (--)
Loading... - Market loading

Insight Molecular Diagnostics (IMDX) Stock Price & Financial Analysis

Insight Molecular Diagnostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.55 - $6.35
52-Week High$8.51
52-Week Low$2.33
Open$6.23
Volume323.24K
Average Volume (3M)469.11K
Market Cap203.61M
Shares Outstanding32.06M
Price to Sales (P/S)50.69
Price to Book (P/B)-6.53
EV/EBITDA-4.10
Revenue (TTM)4.05M
Net Income (TTM)-50.22M
Free Cash Flow (TTM)-25.37M
EPS (TTM)$-1.65
Profit Margin-1238.52%
Operating Margin-844.91%
50-Day MA$4.18
200-Day MA$4.79
52-Week Change74.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Insight Molecular Diagnostics

What is the current stock price for IMDX?

As of the latest trading session, IMDX stock trades at $5.56. The 52-week range is $2.33–$8.51, with a day range of $5.55–$6.35.

What is the P/E ratio for IMDX?

The P/E ratio (Price-to-Earnings) for IMDX is shown in the Key Statistics section. This valuation metric helps compare Insight Molecular Diagnostics Inc. to industry peers.

Does IMDX pay dividends?

Insight Molecular Diagnostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMDX?

Analyst ratings and recommendations for IMDX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of IMDX?

Insight Molecular Diagnostics's market capitalization is $178.3M, classifying it as a micro-cap company. Insight Molecular Diagnostics operates in the Healthcare sector within the Diagnostics & Research industry.